A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions like fibromyalgia and nerve pain, researchers found little convincing evidence of real benefit and flagged serious side effects such as delusions and nausea. The lack of data on whether it reduces depression or opioid use adds to the uncertainty.
source https://www.sciencedaily.com/releases/2025/08/250818102944.htm
AWS Middle East disrupted after ‘objects struck datacenter’ amid Iran war
-
PLUS: AI claims 2,000 jobs at Australia’s WiseTech; Samsung wants humanoid
robots for autonomous factories; Micron opens India plant; And more!
*Asia In b...
7 hours ago
No comments:
Post a Comment